William White

William White

William White joined InvestorPlace.com in 2013. He writes about a wide range of stocks across all industries, especially so-called “meme stocks” or “Reddit stocks.” Recently, his area of expertise has expanded to include cryptocurrencies, such as Bitcoin, Dogecoin, Ripple, and a myriad of other altcoins. Traders looking for additional insight into the stock market can follow him on Twitter.

Recent Articles

Why Is ShiftPixy (PIXY) Stock Up 52% Today?

ShiftPixy stock is on the rise Wednesday as shares of PIXY experience heavy pre-market trading this morning without clear news.

Why Is NuCana (NCNA) Stock Up 102% Today?

NuCana stock is rising on Wednesday as shares of NCNA experience heavy trading alongside a new patent for the biopharmaceutical company.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Pre-market stock movers are a great way to start the day with all of the hottest news worth reading about on Wednesday morning!

Why Is Spectral AI (MDAI) Stock Up 15% Today?

Spectral AI stock is rising on Tuesday as investors react to MDAI securing a $500,000 contract from the U.S. government.

Why Is Assure Holdings (IONM) Stock Up 44% Today?

Assure Holdings stock is up on Tuesday as investors in IONM shares react to news of a $4.5 million asset sale to MPOWERHealth.

KSS Stock Alert: Kohl’s Is Bringing Babies R Us to Its Stores

Kohl's stock is in the news Tuesday as KSS investors learn that Babies R Us stores are coming to the retailer's locations this year.

Why Are Airline Stocks Down Today?

Airline stocks are down on Tuesday as investors deal with several bits of bad news for the industry on Tuesday!

XRP Price Predictions: Where Will a New Bull Run Take the XRP Crypto?

XRP price predictions are a hot topic on Tuesday as the token continues to rally alongside a bull market and oil investments.

Why Is Acadia Pharmaceuticals (ACAD) Stock Down 18% Today?

Acadia Pharmaceuticals stock is falling on Tuesday as investors in ACAD react to its failed Phase 3 clinical trial of pimavanserin.

Why Is CytomX Therapeutics (CTMX) Stock Down 18% Today?

CytomX Therapeutics stock is falling hard on Friday as CTMX shareholders appear unimpressed by its latest earnings report.